Ste20 Inhibitors
Ste20 inhibitors are a class of chemicals that can potentially inhibit the function of the Ste20 protein, a serine/threonine kinase involved in various signaling pathways, including the mitogen-activated protein kinase (MAPK) and protein kinase C (PKC) pathways. Ste20 plays a crucial role in transmitting extracellular signals to downstream kinases, regulating cellular processes such as cell growth, proliferation, and apoptosis. The inhibitors of Ste20 can act through different mechanisms to disrupt its function and downstream signaling pathways. SP600125 is a synthetic compound that selectively inhibits the c-Jun N-terminal kinase (JNK) signaling pathway, preventing the activation and phosphorylation of Ste20. SB 203580 targets the p38 MAPK pathway, inhibiting the activation of p38 MAPK kinase, which phosphorylates and activates Ste20. Wortmannin and LY 294002 inhibit Ste20 by targeting the phosphatidylinositol 3-kinase (PI3K) pathway, blocking the activation of downstream kinases, including Ste20.
Gö 6976 and Bisindolylmaleimide I (GF 109203X) specifically inhibit the protein kinase C (PKC) pathway, blocking the activation and phosphorylation of Ste20. Staurosporine is a potent protein kinase inhibitor that directly binds to the ATP-binding site of Ste20, inhibiting its kinase activity. Calphostin C and H-7 act as PKC inhibitors, competing with ATP binding to PKC and preventing its activation and downstream phosphorylation of Ste20. H-89 dihydrochloride targets protein kinase A (PKA), acting as a competitive inhibitor and blocking its activation and phosphorylation of Ste20. H-1152 dihydrochloride and Y-27632, free base selectively inhibit the Rho-associated protein kinase (ROCK) pathway, preventing the activation and phosphorylation of Ste20. These inhibitors disrupt the signaling cascades downstream of Ste20, ultimately inhibiting its function and affecting cellular processes regulated by Ste20. In summary, Ste20 inhibitors are a diverse group of chemicals that can disrupt the function of Ste20 and its downstream signaling pathways. These inhibitors can act through various mechanisms, including targeting specific kinases involved in Ste20 activation or directly inhibiting Ste20's kinase activity. By inhibiting Ste20, these chemicals can potentially modulate cellular processes regulated by Ste20, providing valuable tools for studying its function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a synthetic compound that can inhibit Ste20 by specifically targeting the c-Jun N-terminal kinase (JNK) signaling pathway. It acts as a selective inhibitor of JNK, preventing its activation and downstream phosphorylation of Ste20, leading to the inhibition of Ste20-mediated signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 is a synthetic compound that can inhibit Ste20 by targeting the p38 MAPK signaling pathway. It specifically inhibits the p38 MAPK kinase, which phosphorylates and activates Ste20, leading to the inhibition of Ste20-mediated signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a natural compound that can inhibit Ste20 by targeting the phosphatidylinositol 3-kinase (PI3K) signaling pathway. It irreversibly inhibits PI3K, preventing the activation of downstream kinases, including Ste20, and inhibiting their signaling cascades. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 is a synthetic compound that can inhibit Ste20 by targeting the PI3K signaling pathway. It acts as a reversible inhibitor of PI3K, blocking the activation of downstream kinases, including Ste20, and inhibiting their signaling cascades. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
Gö 6976 is a synthetic compound that can inhibit Ste20 by specifically targeting the protein kinase C (PKC) signaling pathway. It acts as a selective inhibitor of conventional PKC isoforms, blocking their activation and downstream phosphorylation of Ste20, leading to the inhibition of Ste20-mediated signaling. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I (GF 109203X) is a synthetic compound that can inhibit Ste20 by acting as a potent PKC inhibitor. It competes with the binding of ATP to PKC, preventing its activation and downstream phosphorylation of Ste20, leading to the inhibition of Ste20-mediated signaling. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a natural compound that can inhibit Ste20 by acting as a potent protein kinase inhibitor. It binds to the ATP-binding site of Ste20, preventing its kinase activity and inhibiting downstream signaling pathways. | ||||||
Calphostin C | 121263-19-2 | sc-3545 sc-3545A | 100 µg 1 mg | $343.00 $1642.00 | 20 | |
Calphostin C is a synthetic compound that can inhibit Ste20 by acting as a potent PKC inhibitor. It competes with the binding of ATP to PKC, preventing its activation and downstream phosphorylation of Ste20, leading to the inhibition of Ste20-mediated signaling. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
H-89 is a synthetic compound that can inhibit Ste20 by targeting protein kinase A (PKA). It acts as a competitive inhibitor of PKA, blocking its activation and downstream phosphorylation of Ste20, leading to the inhibition of Ste20-mediated signaling. | ||||||
H-1152 dihydrochloride | 451462-58-1 | sc-203592 sc-203592A | 1 mg 5 mg | $104.00 $364.00 | 7 | |
H-1152 dihydrochloride is a synthetic compound that can inhibit Ste20 by specifically targeting the Rho-associated protein kinase (ROCK) signaling pathway. It acts as a selective inhibitor of ROCK, preventing its activation and downstream phosphorylation of Ste20, leading to the inhibition of Ste20-mediated signaling. | ||||||